| A Study to Assess the Safety and Efficacy of ASP4345 as Add-on Treatment for Cognitive Impairment in Subjects With Schizophrenia on Stable Doses of Antipsychotic Medication (NCT03557931) | Astellas Pharma Global Development, Inc. | 2018-07-13 |
| Comparative Bioavailability of Risperidone (NCT03527186) | Rovi Pharmaceuticals Laboratories | 2018-07-09 |
| ERG Components in Schizophrenia and Bipolar Disorder Type I (NCT03788811) | diaMentis Inc. | 2018-07-05 |
| Validation of a Tool for the Dimensional Assessment of Apathy in a Population Suffering From Schizophrenia. (NCT03801551) | Centre Hospitalier de Niort | 2018-07-03 |
| Effects of Hyperprolactinemia Induced by Antipsychotic Drugs on Bone Metabolism (NCT03675750) | Shanghai Mental Health Center | 2018-07-01 |
| Ningbo Schizophrenia Cohort (NCT06370793) | Ningbo University | 2018-07-01 |
| Combining rTMS With Varenicline to Prevent Smoking Lapse in Schizophrenia (NCT03497299) | Centre for Addiction and Mental Health | 2018-07-01 |
| A Trial to Measure the Difference in All-cause Hospitalizations for Participants Who Are Using Abilify MyCite Versus Virtual Matched Controls in Adults With Schizophrenia, Bipolar 1 Disorder, and Major Depressive Disorder (NCT03643159) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2018-06-28 |
| A Safety, Tolerability, and Pharmacokinetics Study of MK-8189 in Participants With Schizophrenia and in Healthy Participants (MK-8189-007) (NCT03565068) | Merck Sharp & Dohme LLC | 2018-06-20 |
| Effect of Dietary Fiber Supplement on the Intestinal Microbiota Among Schizophrenia Patients (NCT03552237) | TsaoTun Psychiatric Center, Department of Health, Taiwan | 2018-06-20 |
| Controlled Trial of Brexpiprazole For The Treatment of Co-occurring Schizophrenia and Substance Use Disorder (NCT03526354) | University of Massachusetts, Worcester | 2018-06-19 |
| Therapeutic Drug Monitoring for Individualized Clozapine Therapy (NCT03523741) | Seoul National University Hospital | 2018-06-13 |
| Substance Misuse To Psychosis for Ketamine (SToP-K) (NCT03485339) | The University of Hong Kong | 2018-06-12 |
| A Study to Determine the Maximum Tolerated Dose of an Investigational Drug in Subjects With Schizophrenia (NCT03627195) | Sumitomo Pharma America, Inc. | 2018-06-07 |
| Effectiveness of Aripiprazole Long-acting Injection in Recent Onset and Chronic Schizophrenia Patients (NCT03839251) | Chonbuk National University Hospital | 2018-06-01 |
| Assessment of Efficacy of a Psychological Therapy in Inpatients With a Schizophrenic Psychosis (NCT03316664) | Psychiatric University Hospital, Zurich | 2018-06-01 |
| Remediation of Visual Perceptual Impairments in People With Schizophrenia (NCT03314129) | University of Rochester | 2018-06-01 |
| A Trial to Explore Acceptance and Performance of Using a Digital Medicine System With Healthcare Professionals and Adults With Schizophrenia, Schizoaffective Disorder, or First Episode Psychosis on an Oral Atypical Antipsychotic (NCT03568500) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2018-05-21 |
| Transcranial Direct Current Stimulation and Effects on Early Auditory Processing in Schizophrenia (NCT03537703) | VA Greater Los Angeles Healthcare System | 2018-05-20 |
| Therapeutic Effect of Cassia Seed in Obesity of Patients With Schizophrenia (NCT04252131) | Calo Psychiatric Center | 2018-05-17 |
| Individualizing Incentives for Alcohol in the Severely Mentally Ill (NCT03481049) | Washington State University | 2018-05-05 |
| The Effect of a Community-based LAT-treated Management Model on the Violence Risk of Patients With Schizophrenia (NCT03434210) | Yi Li MD, PhD | 2018-05-05 |
| Study to Evaluate TV-46000 as Maintenance Treatment in Adult and Adolescent Participants With Schizophrenia (NCT03503318) | Teva Branded Pharmaceutical Products R&D, Inc. | 2018-04-27 |
| Berberine as Adjuvant Treatment for Schizophrenia Patients (NCT02983188) | The University of Hong Kong | 2018-04-25 |
| Augmentation of Working Memory Training With Transcranial Direct Current Stimulation in Patients With Schizophrenia (NCT03621540) | University Hospital Tuebingen | 2018-04-20 |
| Boost rTMS for Auditory Verbal Hallucinations (NCT03544333) | Northwell Health | 2018-04-16 |
| OnTrackNY With the Option of Social Network Meetings (NCT03464162) | Lisa Dixon | 2018-04-11 |
| Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia (NCT03860597) | University of California, San Diego | 2018-04-01 |
| The Application of Wearable Technology to Improve the Physical Activity Level of People With Chronic Mental Illness (NCT03408327) | Kaohsiung Medical University Chung-Ho Memorial Hospital | 2018-03-16 |
| Touchscreen-based Cognitive Tests in Healthy Volunteers (NCT03469089) | University of Eastern Finland | 2018-03-12 |
| Texting for Relapse Prevention (NCT02819349) | Center for Innovative Public Health Research | 2018-03-12 |
| A Clinical Study to Evaluate the Bioavailability Between Two Products Containing Paliperidone 100 mg in the Form of a Prolonged Release Suspension for Injection in Patients With Schizophrenia Who Are Already Stabilized in This Treatment (NCT03425552) | Pharmathen S.A. | 2018-03-11 |
| Cost-utility Study of a Group of Compensatory Cognitive Remediation in Schizophrenia (NCT02879604) | University Hospital, Montpellier | 2018-03-05 |
| A Neurofeedback Intervention to Improve Working Memory in Schizophrenia (NCT03260257) | University of California, San Diego | 2018-03-01 |
| Rt-fMRI Neurofeedback and AH in Schizophrenia (NCT03504579) | Harvard Medical School (HMS and HSDM) | 2018-03-01 |
| Mindfulness Group-based Intervention for Early Psychosis (NCT03143907) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2018-02-22 |
| Early Detection of Respiratory Disorders in Psychosis (NCT03476473) | Fundación Marques de Valdecilla | 2018-02-16 |
| Searching for Early Biomarkers of Long-term Hepatic, Metabolic and Endothelial Dysfunction in Non-affective Psychosis (NCT03481465) | Fundación Marques de Valdecilla | 2018-02-12 |
| Gut Microbiome in AP Naive (NCT03414151) | Centre for Addiction and Mental Health | 2018-02-07 |
| Links Between Perception of Temporal Order Judgment and Causality in Schizophrenia (NCT03432000) | Hôpital le Vinatier | 2018-02-01 |
| Optimizing and Individualizing the Pharmacological Treatment of First-episode Schizophrenic Patients (NCT03451734) | Central South University | 2018-01-23 |
| Feasibility and Relevance of High-Intensity Functional Training in Patients With First-Episode Psychosis (NCT03409393) | Rigshospitalet, Denmark | 2018-01-22 |
| A Study to Assess the Safety, Tolerability, Pharmacodynamics and Pharmacokinetics of ASP6981 in Subjects With Schizophrenia (NCT03356639) | Astellas Pharma Global Development, Inc. | 2018-01-22 |
| EfiKroniK Research Program: Physical Exercise for People With Chronic Pathologies (NCT03810755) | Basque Health Service | 2018-01-10 |
| A Study to Evaluate Multiple Oral Doses of Luvadaxistat in Adults With Schizophrenia (NCT03359785) | Neurocrine Biosciences | 2018-01-10 |
| Compensatory Cognitive Training For Schizophrenia (NCT04040998) | Taoyuan Psychiatric Center, Ministry of Health and Welfare, Executive Yuan, R.O.C. Taiwan | 2018-01-05 |
| Target Engagement and Response to Oxytocin (NCT03245437) | University of California, Los Angeles | 2018-01-04 |
| A Study of Lurasidone HCl in Subjects With Schizophrenia (NCT03393026) | Standard Chem. & Pharm. Co., Ltd. | 2018-01-03 |
| Cognate Patient Care Insight Scale (NCT03071939) | Hôpital le Vinatier | 2018-01-02 |
| Monotherapy of an NMDA Enhancer for Schizophrenia (NCT04745143) | China Medical University Hospital | 2018-01-01 |
| Validating and Optimizing Model of Antipsychotics Selection (NCT03237052) | Shanghai Mental Health Center | 2018-01-01 |
| Effect of Intranasal Vasopressin on Cooperative Behavior in Schizophrenia (NCT04190004) | National Institute of Mental Health and Neuro Sciences, India | 2018-01-01 |
| Influence of Amphetamine-induced Sensitization on Dopamine Synthesis and Release (NCT03223844) | Medical University of Vienna | 2018-01-01 |
| Community-based Mental Health Care for People With Severe and Enduring Mental III Health ( RECOVER-E ) (NCT03892473) | University of Skopje | 2018-01-01 |
| Community-based Mental Health Care for People With Severe and Enduring Mental III Health (NCT03922425) | The National Center for Public Health and Analyzes, Bulgaria | 2018-01-01 |
| Cognitive Remediation Program for Hospitalized in the Long Term Patients With Deficit Schizophrenia (NCT03407950) | University Hospital, Montpellier | 2018-01-01 |
| Community-based Mental Health Care for People With Severe and Enduring Mental Ill Health (NCT03837340) | Special Psychiatric Hospital Kotor | 2018-01-01 |
| This Study Tests Whether BI 409306 Prevents Patients With Schizophrenia From Becoming Worse. This Study Looks at How Well Patients Tolerate BI 409306 and How Effective it is Over 6 Months (NCT03351244) | Boehringer Ingelheim | 2017-12-07 |
| The Evaluation of the Use of a New Physical Health Plan (NCT03178279) | King's College London | 2017-12-06 |
| Exercise Intervention for People With Schizophrenia (CREW) (NCT06044038) | Università degli Studi di Ferrara | 2017-12-01 |
| Stimulating the Brain to Improve Self-Awareness (NCT03370341) | The University of Texas at Dallas | 2017-12-01 |
| Modulating Human Cortical Plasticity With Transcranial Electrical Stimulation (NCT03114488) | University of Minnesota | 2017-12-01 |
| Cerebellar Stimulation and Cognitive Control (NCT03217110) | Krystal Parker, PhD | 2017-11-30 |
| A 12-weeks Study to Evaluate the Dietary Fiber and Probiotics Treatment in Prevention and Intervention of Weight-gain and Cognitive Impairment of Schizophrenia or Bipolar Disorder (NCT03379597) | Central South University | 2017-11-30 |
| Study Assessing the Safety, Tolerability, and Pharmacokinetics of SEP-363856 in Japanese Male and Female Subjects With Schizophrenia in 2 Parts (Part 1 and 2). (NCT03370640) | Sumitomo Pharma Co., Ltd. | 2017-11-29 |
| MAintain the Efficacy and Safety in Treatment of Schizophrenia After Switching to Long-acTing Injectable aRipiprazole From Oral Atypical Antipsychotics (NCT03376763) | Korea Otsuka Pharmaceutical Co., Ltd. | 2017-11-21 |
| Proposal To Develop A Rapid And Cost-Effective Diagnostic Test For Schizophrenia (NCT03781115) | University of Arizona | 2017-11-20 |
| A Study of Paliperidone Palmitate 6-Month Formulation (NCT03345342) | Janssen Research & Development, LLC | 2017-11-20 |
| A Study of Aripiprazole Lauroxil or Paliperidone Palmitate for the Treatment of Schizophrenia (NCT03345979) | Alkermes, Inc. | 2017-11-15 |
| Targeting Auditory Hallucinations With Alternating Current Stimulation (NCT03221270) | University of North Carolina, Chapel Hill | 2017-11-14 |
| Endocannabinoid Control of Microglia Activation as a New Therapeutic Target in the Treatment of Schizophrenia (NCT02932605) | UMC Utrecht | 2017-11-03 |
| [18 Fluorine(F)]DOPA Determinants and Predictors of Treatment Response in Psychosis (NCT02880995) | Seoul National University Hospital | 2017-11-01 |
| Pharmacogenomic and Pharmacoepigenomic Studies of Antipsychotic Drugs in First-Episode Schizophrenia (NCT07102069) | Tianjin Anding Hospital | 2017-11-01 |
| Theta Burst Stimulation for Schizophrenia (NCT03288779) | Duke University | 2017-10-24 |
| A Research in Pharmacogenomics and Accurate Medication of Risperidone (NCT03302364) | Cui Yimin | 2017-10-22 |
| Visual Information Processing in Schizophrenia Patients With Visual Hallucinations (NCT03188133) | Central Hospital, Nancy, France | 2017-10-17 |
| Effectiveness of a Mobile Texting Intervention for People With Serious Mental Illness (NCT03062267) | University of Washington | 2017-10-01 |
| Clinical Evaluation of Acupuncture Treatment for Negative Symptoms of Schizophrenia (NCT03802838) | Shanghai Mental Health Center | 2017-10-01 |
| A Controlled Study With Remote Web-based Adapted Physical Activity (e-APA) in Psychotic Disorders (NCT03261817) | University Hospital, Caen | 2017-09-29 |
| Involuntary Memories Investigation in Schizophrenia (NCT03209778) | University Hospital, Strasbourg, France | 2017-09-29 |
| TMS Enhancement of Visual Plasticity in Schizophrenia (NCT03220438) | University of Maryland, Baltimore | 2017-09-27 |
| VIA Family - Family Based Early Intervention Versus Treatment as Usual (NCT03497663) | Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital | 2017-09-25 |
| Neural Biomarkers of Clozapine Response (NCT03076346) | University of Pittsburgh | 2017-09-01 |
| Symptom Based Treatment Affects Brain Plasticity - Cognitive Training in Patients With Affective Symptoms (NCT03183947) | RWTH Aachen University | 2017-08-29 |
| Metformin Treatment on Cognitive Impairment of Schizophrenia Co-morbid Metabolic Syndrome (NCT03271866) | Central South University | 2017-08-28 |
| Study to Evaluate the Efficacy and Safety of Risperidone ISM® in Patients With Acute Schizophrenia: Open Label Extension (NCT03870880) | Rovi Pharmaceuticals Laboratories | 2017-08-25 |
| Lurasidone Vs Olanzapine on Neurotrophic Biomarkers and Cardiometabolic Parameters in Unmedicated Schizophrenia (NCT03304457) | All India Institute of Medical Sciences, Bhubaneswar | 2017-08-25 |
| Safety and Tolerability of Open-Label Flexible-dose Brexpiprazole as Maintenance Treatment in Adolescents With Schizophrenia (NCT03238326) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2017-08-23 |
| Levetiracetam in Early Psychosis (NCT03129360) | NYU Langone Health | 2017-08-18 |
| Comparison of Propofol Target-Controlled Infusion Anesthesia and Bolus Injection in Electroconvulsive Therapy (NCT03863925) | Chang Gung Memorial Hospital | 2017-08-15 |
| Level of Immersion of Virtual Reality and Cognition and Motor Performance in Patients of Schizophrenia Spectrum Disorder (NCT04629898) | National Taiwan Normal University | 2017-08-01 |
| Aspirin in Young Psychotic Patients (NCT02685748) | Clinic for Psychiatric Disorders, Dr Laza Lazarevic | 2017-07-20 |
| Predictors of Persistence in Patients With Schizophrenia Treated With Once-monthly Aripiprazole in Spain (NCT03130478) | Otsuka Pharmaceutical Europe Ltd | 2017-07-18 |
| The Effects of Bimodal tDCS on Illness Severity, Insight, Functional Outcomes, Neurocognition and HRV in Schizophrenia (NCT03701100) | Tri-Service General Hospital (TSGH) | 2017-07-17 |
| Aripiprazole Once-monthly Versus Daily Oral Atypical Antipsychotic Treatment in Patients With Recent-onset Schizophrenia (NCT03130465) | Otsuka Pharmaceutical Europe Ltd | 2017-07-13 |
| Confirmatory Efficacy Trial of a Gluten-Free Diet in a Subgroup of Persons With Schizophrenia Who Have High Levels of IgG Anti-Gliadin Antibodies (AGA IG) (NCT03183609) | University of Maryland, Baltimore | 2017-07-10 |
| Lifestyle Intervention for Young Adults With Serious Mental Illness (NCT02815813) | Dartmouth-Hitchcock Medical Center | 2017-07-03 |
| Financial Incentives to Improve Acceptance of Antipsychotic Injections (NCT03192631) | Focus Community Mental Health Team | 2017-07-01 |
| Evaluation of Executive Function With Virtual Reality Among People With Schizophrenia (NCT03146364) | HaEmek Medical Center, Israel | 2017-07-01 |
| The Mid-term Effect of Repeated Transcranial Magnetic Stimulation on Schizophrenia (NCT03940898) | Shanghai Mental Health Center | 2017-07-01 |